是一种潜在的抗肥胖剂吗?
Nilüfer Acar Tek1, Şerife Akpınar Şentüre2, Nursena Ersoy3
1Faculty of Health Science, Department of Nutrition and Dietetic, Gazi University, Emek, Bişkek Main St. 6. St No: 2, 06490, Çankaya, Ankara, Turkey.
Current nutrition reports
|March 4, 2024
概括
蜂是一种天然蜜蜂产品,通过增加能源消耗来帮助减肥. 它的多促进脂肪组织的色,并激活新陈代谢途径,提供一种天然的抗肥胖策略.
科学领域:
- 蜜蜂产品研究 蜜蜂产品研究
- 代谢研究的研究.
- 肥胖研究的研究.
背景情况:
- 蜂是一种天然蜜蜂产生的树脂,具有悠久的传统使用历史.
- 它的化学成分和生物活动在地理上是可变的.
- 现代研究研究了石的治疗潜力.
研究的目的:
- 综合审查的结构和生物特性.
- 探索的潜力作为一种体重管理策略.
- 调查粉影响能量消耗和脂肪代谢的机制.
主要方法:
- 关于的科学研究的文献综述.
- 对的组成和生物活动的研究分析.
- 检查研究的研究,探讨 прополис对热生成和代谢途径的影响.
主要成果:
- 的多会在棕色和色脂肪组织中诱导热生成.
- 关键的类化合物,如阿尔特皮林C和奎尔塞丁,表现出抗肥胖作用.
- 机制包括交感神经系统刺激,白色脂肪组织色,AMP激活蛋白激酶 (AMPK) 和线粒体生物发生的激活.
结论:
- 树在体重管理方面具有显著的潜力.
- 它的化合物有效地增加能量消耗,并对抗肥胖.
- 普罗波利斯提供了一个有希望的基于天然产品的战略,以应对全球肥胖流行病.
相关概念视频
Obesity
498
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
498
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
175
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
175
Glucagon-like Receptor Agonists
321
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321
Regulation of Food Intake
228
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
228
Oral Hypoglycemic Agents: Biguanides and Glitazones
199
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199
Hormonal Regulation
43.5K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.5K


